PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.\', \'Pathology Department, Amsterdam UMC, VUmc site, Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/cei.13495
?:doi
?:hasPublicationType
?:journal
  • Clinical and experimental immunology
is ?:pmid of
?:pmid
?:pmid
  • 32671831
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.431
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32671831>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32671831>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all